OPEN END TURBO BEAR OPTIONSSCHEIN - ELI LILLY & CO | Market Closed - BOERSE MUENCHEN 15:41:50 2024-06-28 EDT | ||
| 3.12 EUR | -13.81% |
|
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
Latest news about ELI LILLY AND COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 24-06-28 | 3.12 | -13.81% |
| 24-06-27 | 3.62 | -9.27% |
| 24-06-26 | 3.99 | +1.27% |
| 24-06-25 | 3.94 | -16.53% |
| 24-06-24 | 4.72 | -12.75% |
Real-time BOERSE MUENCHEN
Last update June 28, 2024 at 03:41 pm
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | 
UniCredit
|
| WKN | HD65RL |
| ISIN | DE000HD65RL8 |
| Date issued | 2024-06-05 |
| Strike | 940.8 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 10.06 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 11.18 € |
|---|---|
| Lowest since issue | 2.88 € |
| Spread | 0.09 € |
| Spread % | 2.52% |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
905.4
USD
Average target price
868.9
USD
Spread / Average Target
-4.03%
- Stock Market
- Certificates
- Certificat
